NCT05437003View on ClinicalTrials.gov

A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients

NACompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

August 20, 2022

Primary Completion Date

February 15, 2024

Study Completion Date

February 15, 2024

Conditions
Idiopathic Parkinson Disease
Interventions
OTHER

NeuraLight software-based platform

NeuraLight is an investigational software-based platform that is used for assessment and evaluation of neurological conditions including PD patients

Trial Locations (1)

4941492

Rabin Medical Center, Petah Tikva

Sponsors

Lead Sponsor

NeuraLight
All Listed Sponsors
lead

NeuraLight

INDUSTRY

NCT05437003 - A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients | Biotech Hunter | Biotech Hunter